schering plough corp schering plough corp terminated a development pact with metabasis therapeutics inc and valeant pharmaceuticals international after a clinical trial of a hepatitis drug showed increased incidence of cancer in mice and rats at high doses the companies reached a development and commercialization agreement in december for the drug called pradefovir designed to treat chronic hepatitis b valeant a costa mesa calif pharmaceuticals company originally licensed the drug from metabasis a san diego biopharmaceuticals company in 
